A5008831879- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Cardiac Structural Anomalies and Repair
- Pericarditis and Cardiac Tamponade
- Takotsubo Cardiomyopathy and Associated Phenomena
- Mechanical Circulatory Support Devices
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
- Peripheral Artery Disease Management
- Infective Endocarditis Diagnosis and Management
- Cardiac pacing and defibrillation studies
- Vascular Procedures and Complications
- Cardiac Arrest and Resuscitation
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Issues in Pregnancy
- Viral Infections and Immunology Research
- Coronary Artery Anomalies
- Cerebrovascular and Carotid Artery Diseases
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Aortic Disease and Treatment Approaches
- Aortic aneurysm repair treatments
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Syncope and Autonomic Disorders
- Pulmonary Hypertension Research and Treatments
St. Francis Medical Center
2020-2025
Women & Infants Hospital of Rhode Island
2025
Providence College
2025
Bahawal Victoria Hospital
2024
Saint Francis Medical Center
2020-2024
St Francis Medical Center
2023
MedStar Washington Hospital Center
2017-2022
Memorial Hospital of Carbondale
2021
Westchester Medical Center
2021
Northeast Ohio Medical University
2021
Importance There are limited data to guide practices reduce surgical site infections following sacral neuromodulation; however, many surgeons prescribe prophylactic postoperative antibiotics after device implantation. Objective The aim of the study was compare proportion patients with neuromodulation device-associated use versus none. Study Design This a multicenter retrospective cohort undergoing implantation at 11 institutions from January 2014 December 2023, comparing outcomes in who did...
Robust data on the commonly reported complications and failure modes associated with Impella (Abiomed Inc, Danvers, MA) is limited. We analyzed post-marketing surveillance from Food Drug Administration Manufacturer User Facility Device Experience (MAUDE) database to assess these
[Figure: see text].
We describe herein a 61-year-old African American woman who presented with takotsubo cardiomyopathy preceded by lupus myopericarditis. The case highlights the importance of association between pericarditis and cardiomyopathy. This new stressor adds to existing evidence that these two entities may coexist do not have be mutually exclusive.
We analyzed post-marketing surveillance data from the United States Food and Drug Administration (FDA) Manufacturer User Facility Device Experience (MAUDE) database for suture-based vascular closure devices (VCDs) - Perclose ProGlide (Abbott, Chicago, Illinois) Prostar XL (Abbott).Suture-based VCDs are mostly used large-bore femoral arterial access-site closure. Real-world, contemporary experience on most commonly reported complications modes of failure associated with these is...
Abstract Objectives To assess the commonly reported complications and failure modes for FilterWire EZ Embolic Protection Devices (EPD) by analyzing postmarketing surveillance data from Food Drug Administration (FDA) Manufacturer User Facility Device Experience (MAUDE) database. Background EPDs prevent distal embolization of atheroembolic materials during percutaneous interventions resulting in reduced microvascular obstruction improved microcirculation while maintaining tissue perfusion. The...